Key points are not available for this paper at this time.
These findings suggest that the potential of sevoflurane in protecting the lungs donated after cardiac death and reconditioned using EVLP could improve the outcome of these lungs following subsequent transplantation.
Wang et al. (Thu,) studied this question.